Literature DB >> 3013796

Acceleration of scrapie disease in mice by an adenovirus.

D W Ehresmann, R N Hogan.   

Abstract

Coinfected mice were examined for a possible interaction between the scrapie agent and an adenovirus. A low titer (10(2) TCD50) of mouse adenovirus (MAdV) caused a significant acceleration of clinical signs of scrapie in mice infected 128 days previously with scrapie. In this experiment, the coinfected mice died 19 days earlier than mice infected with scrapie alone. When a higher titer of MAdV (10(4)-10(5) PFU) was used, a more drastic acceleration of scrapie disease was seen in mice infected 85 and 110 days previously with scrapie. At 85 days, coinfection caused mice to die 37 days earlier than mice infected with scrapie alone, whereas at 110 days, coinfection caused mice to die 52 days earlier than mice infected with scrapie alone. MAdV alone caused no clinical disease in normal mice. The brains of coinfected mice and mice that had been infected with scrapie alone showed a histopathology consistent with scrapie. A possible explanation for these findings is that the replication of the scrapie agent is accelerated by adenovirus. Defective parvoviruses are known to be helped by adenoviruses. Spleens from coinfected mice but not from mice infected with MAdV alone yielded, in cultures of BALB 3T3 cells, infectious MAdV and one or two smaller agents with the dimension and shape of a parvovirus.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3013796     DOI: 10.1159/000149663

Source DB:  PubMed          Journal:  Intervirology        ISSN: 0300-5526            Impact factor:   1.763


  8 in total

1.  Poliovirus type 1 infection of murine PRNP-knockout neuronal cells.

Authors:  Andreina Baj; Alessia Bettaccini; Takuya Nishimura; Takashi Onodera; Antonio Toniolo
Journal:  J Neurovirol       Date:  2005-07       Impact factor: 2.643

2.  Accelerated prion disease pathogenesis in Toll-like receptor 4 signaling-mutant mice.

Authors:  Daryl S Spinner; In Soo Cho; Seung Yong Park; Jae Il Kim; Harry C Meeker; Xuemin Ye; Giuseppe Lafauci; Daniel J Kerr; Michael J Flory; Bo Sook Kim; Regina B Kascsak; Thomas Wisniewski; William R Levis; Georgia B Schuller-Levis; Richard I Carp; Eunkyue Park; Richard J Kascsak
Journal:  J Virol       Date:  2008-08-20       Impact factor: 5.103

3.  Systemic challenge with the TLR3 agonist poly I:C induces amplified IFNalpha/beta and IL-1beta responses in the diseased brain and exacerbates chronic neurodegeneration.

Authors:  Robert Field; Suzanne Campion; Colleen Warren; Carol Murray; Colm Cunningham
Journal:  Brain Behav Immun       Date:  2010-04-23       Impact factor: 7.217

4.  Co-infection with the friend retrovirus and mouse scrapie does not alter prion disease pathogenesis in susceptible mice.

Authors:  Pascal Leblanc; Kim Hasenkrug; Anne Ward; Lara Myers; Ronald J Messer; Sandrine Alais; Andrew Timmes; Suzette A Priola; Sue Priola
Journal:  PLoS One       Date:  2012-01-25       Impact factor: 3.240

Review 5.  Potential detrimental effects of rodent viral infections on long-term experiments.

Authors:  G Lussier
Journal:  Vet Res Commun       Date:  1988       Impact factor: 2.459

6.  The first non-prion pathogen identified: neurotropic influenza virus.

Authors:  Suehiro Sakaguchi; Hideyuki Hara
Journal:  Prion       Date:  2022-12       Impact factor: 3.931

Review 7.  Virus Infection, Genetic Mutations, and Prion Infection in Prion Protein Conversion.

Authors:  Hideyuki Hara; Suehiro Sakaguchi
Journal:  Int J Mol Sci       Date:  2021-11-18       Impact factor: 5.923

Review 8.  The Effects of Immune System Modulation on Prion Disease Susceptibility and Pathogenesis.

Authors:  Neil A Mabbott; Barry M Bradford; Reiss Pal; Rachel Young; David S Donaldson
Journal:  Int J Mol Sci       Date:  2020-10-02       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.